These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26897363)

  • 1. The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models.
    Halliday A; Turner JD; Guimarães A; Bates PA; Taylor MJ
    Parasit Vectors; 2016 Feb; 9():96. PubMed ID: 26897363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated bisacycloxypropylcysteine, a diacylated lipopeptide ligand of TLR6, plays a host-protective role against experimental Leishmania major infection.
    Pandey SP; Chandel HS; Srivastava S; Selvaraj S; Jha MK; Shukla D; Ebensen T; Guzman CA; Saha B
    J Immunol; 2014 Oct; 193(7):3632-43. PubMed ID: 25194056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immune response elicited by inulin as an adjuvant with filarial antigens in mice model.
    Mahalakshmi N; Aparnaa R; Kaliraj P
    Scand J Immunol; 2014 Oct; 80(4):261-70. PubMed ID: 25041426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avian influenza virus vaccines containing Toll-like receptors 2 and 5 ligand adjuvants promote protective immune responses in chickens.
    St Paul M; Brisbin JT; Barjesteh N; Villaneueva AI; Parvizi P; Read LR; Nagy E; Sharif S
    Viral Immunol; 2014 May; 27(4):160-6. PubMed ID: 24797722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troponin 1 of human filarial parasite Brugia malayi: cDNA cloning, expression, purification, and its immunoprophylactic potential.
    Kushwaha V; Tewari P; Mandal P; Tripathi A; Murthy PK
    Parasitol Res; 2019 Jun; 118(6):1849-1863. PubMed ID: 31055672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection.
    Daifalla NS; Bayih AG; Gedamu L
    Exp Parasitol; 2012 Jul; 131(3):317-24. PubMed ID: 22580023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(d,l)-lactide-co-glycolide (PLGA) microspheres as immunoadjuvant for Brugia malayi antigens.
    Saini V; Verma SK; Murthy PK; Kohli D
    Vaccine; 2013 Aug; 31(38):4183-91. PubMed ID: 23827312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis.
    Chauhan N; Banerjee P; Khatri VK; Canciamille A; Gilles J; Kalyanasundaram R
    Parasitol Res; 2017 Oct; 116(10):2821-2830. PubMed ID: 28828575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a Toll-like receptor 7 and/or 8 agonist vaccine adjuvant increases protective immunity against Leishmania major in BALB/c mice.
    Zhang WW; Matlashewski G
    Infect Immun; 2008 Aug; 76(8):3777-83. PubMed ID: 18474642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoadjuvant effect of diethylcarbamazine in experimental filariasis.
    Parasurama Jawaharlal JP; Rajaiah Prabhu P; Gandhirajan A; Krishnan N; Perumal K
    Int Immunopharmacol; 2015 Feb; 24(2):458-462. PubMed ID: 25576657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.
    Ramirez L; Corvo L; Duarte MC; Chávez-Fumagalli MA; Valadares DG; Santos DM; de Oliveira CI; Escutia MR; Alonso C; Bonay P; Tavares CA; Coelho EA; Soto M
    Parasit Vectors; 2014 Jan; 7():3. PubMed ID: 24382098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection.
    Rhee EG; Mendez S; Shah JA; Wu CY; Kirman JR; Turon TN; Davey DF; Davis H; Klinman DM; Coler RN; Sacks DL; Seder RA
    J Exp Med; 2002 Jun; 195(12):1565-73. PubMed ID: 12070284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The adjuvant effects of IL-12 and BCG on autoclaved Leishmania major vaccine in experimental cutaneous leishmaniasis.
    Michel MY; Fathy FM; Hegazy EH; Hussein ED; Eissa MM; Said DE
    J Egypt Soc Parasitol; 2006 Apr; 36(1):159-76, following 76. PubMed ID: 16605109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection of IL-4-deficient mice with the parasitic nematode Brugia malayi demonstrates that host resistance is not dependent on a T helper 2-dominated immune response.
    Lawrence RA; Allen JE; Gregory WF; Kopf M; Maizels RM
    J Immunol; 1995 Jun; 154(11):5995-6001. PubMed ID: 7751642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils.
    Zhan B; Arumugam S; Kennedy MW; Tricoche N; Lian LY; Asojo OA; Bennuru S; Bottazzi ME; Hotez PJ; Lustigman S; Klei TR
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006772. PubMed ID: 30296268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM.
    Hise AG; Daehnel K; Gillette-Ferguson I; Cho E; McGarry HF; Taylor MJ; Golenbock DT; Fitzgerald KA; Kazura JW; Pearlman E
    J Immunol; 2007 Jan; 178(2):1068-76. PubMed ID: 17202370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmanial CpG DNA nanovesicles: A propitious prophylactic approach against visceral leishmaniasis.
    Tiwari RK; Chandrakar P; Gupta CL; Sayyed U; Shekh R; Bajpai P
    Int Immunopharmacol; 2021 Jan; 90():107181. PubMed ID: 33249044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pam3CSK4 adjuvant given intranasally boosts anti-Leishmania immunogenicity but not protective immune responses conferred by LaAg vaccine against visceral leishmaniasis.
    Salgado CL; Dias EL; Stringari LL; Covre LP; Dietze R; Lima Pereira FE; de Matos Guedes HL; Rossi-Bergmann B; Gomes DCO
    Microbes Infect; 2019; 21(7):328-335. PubMed ID: 30817996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.